Effect of amphetamine and phencyclidine on DNA-binding activities of serum response and dyad symmetry elements

Neurochemistry International

Volumn 42, Issue 5, 2003, Pages 409-417

  Milanović, Desanka ^a   Milošević, Javorina ^a   Kanazir, Selma ^a   Rakić, Ljubisav ^b   Ruždijić, Sabera ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

^b SERBIAN ACADEMY OF SCIENCES AND ARTS   (Serbia)

Author keywords

Amphetamine; c fos gene expression; Dyad symmetry element; Phencyclidine; Serum response element

Indexed keywords

DEXAMPHETAMINE; DNA; NUCLEAR PROTEIN; PHENCYCLIDINE; PROTEIN C FOS; PSYCHOSTIMULANT AGENT;

ANIMAL TISSUE; ARTICLE; AUTOREGULATION; BINDING AFFINITY; CONTROLLED STUDY; DNA BINDING; DNA RESPONSIVE ELEMENT; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MALE; NONHUMAN; ONCOGENE C FOS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; RAT; REGULATORY MECHANISM; SERUM RESPONSIVE ELEMENT; TIME;

AMPHETAMINE; ANIMALS; BLOTTING, WESTERN; BRAIN CHEMISTRY; CENTRAL NERVOUS SYSTEM STIMULANTS; DNA TRANSPOSABLE ELEMENTS; ELECTROPHORETIC MOBILITY SHIFT ASSAY; GENES, FOS; HALLUCINOGENS; MALE; PHENCYCLIDINE; PROTO-ONCOGENE PROTEINS C-FOS; RATS;

EID: 0037375531     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00133-X     Document Type: Article

References (51)

1. Adams A.C., Keffe K.A. Degree of immediate early gene induction in striatum by eticlopride determinates sensitivity to N-methyl-D-aspartate receptor blockade. Brain Res. 885:2000;201-207.
2. Armstrong R.C., Montminy M.C. Transsynaptic control of gene expression. Annu. Rev. Neurosci. 16:1993;17-29.
3. Balster R.L., Chait L.D. The effects of phencyclidine on amphetamine stereotipy in rats. Eur. J. Pharmacol. 48:1978;445-450.
4. Bateman E. Autoregulation of eukaryotic transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 60:1998;133-168.
5. Bontempi B., Sharp F.R. Systemic morphine-induced Fos protein in the rat striatum and nucleus accumbens is regulated by μ opioid receptors in the substanta nigra and ventral tegmental area. J. Neurosci. 17:1997;8596-8612.
6. Cahill M.A. c-Fos transrepression revisited. FEBS Lett. 400:1997;9-10.
7. Curran E.J., Akil H., Watson S.J. Psychomotor stimulant- and opiate-induced c-fos mRNA expression patterns in the rat forebrain: comparisons between acute drug treatment and a drug challenge in sensitized animals. Neurochem. Res. 21:1996;1425-1435.
8. Damodaran T.V., Abdel-Rahman A., El-Sourady M.H., Abou-Donia M.B. Differential alteration of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA in the central nervous system of hens treated with diisopropylphosphorofluoridate (DFP). Neurochem. Int. 40:2002;371-379.
9. Gao X.M., Hashimoto T., Tamminga C. Phencyclidine (PCP) and dizocilpine (MK801) exert time dependent effects on the expression of immediate early genes in rat brain. Synapse. 29:1998;14-28.
10. Gauthier-Rouviere C., Basset M., Lamb N.J.C., Fernandez A. Role of fos-AP-1 binding sequence (FAP) in the induction of c-fos expression by purified C-kinase and in c-fos down-regulation following serum induction. Oncogene. 7:1992;363-369.
11. Ghosh A., Greenberg M.E. Calcium signaling in neurons: molecular mechanisms and cellular consequences. Science. 268:1995;239-247.
12. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6912-6916.
13. Gutman A., Wasylyk C., Wasylyk B. Cell-specific regulation of oncogene-responsive sequences of the c-fos promoter. Mol. Cell. Biol. 11:1991;5386-5387.
14. Herdegen T., Leah J.D. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Rev. 28:1998;370-490.
15. Herdegen T., Blume A., Buschmann T., Georgakopoulos E., Winter C., Schmid W., Hsieh T.F., Zimmermann M., Gass P. Expression of activating transcription factor-2, serum response factor and cAMP/Ca response element binding protein in the adult rat brain following generalized seizures, nerve fibre lesion and ultraviolet irradiation. NeuroScience. 81:1997;199-212.
16. Hondo H., Yonezawa Y., Nakahara T., Nakamura K., Hirano M., Uchimura H., Tashiro N. Effect of phencyclidine on dopamine release in the rat prefrontal cortex an in vivo microdialysis study. Brain Res. 633:1994;337-342.
17. Ivkovic S., Kanazir S., Stojiljkovic M., Rakic L.J., Ruzdijic S. Desenzitization of c-fos mRNA expression in rat brain following cortical lesions. Mol. Cell. Neurosci. 5:1994;11-22.
18. Ivkovic S., Kanazir S., Rakic L.J., Ehrlich M.E., Ruzdijic S. Enhanced serum response element binding activity correlates with down-regulation of c-fos mRNA expression in the rat brain following repeated cortical lesions. Mol. Brain Res. 52:1997;62-70.
19. Iwata S.I., Hewlett G.H.K., Gnegy M.E. Amphetamine increases the phosphorylation of neuromodulin and synapsin I in rat striatal synaptosomes. Synapse. 26:1997;281-291.
20. Janknecht R., Hunter T. A growing coactivator network. Nature. 383:1997a;22-23.
21. Janknecht R., Hunter T. Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 16:1997b;1620-1627.
22. Javit D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148:1991;1301-1338.
23. Javitt D.C., Balla A., Sershen H., Lajtha A. Reversal of phencyclidine-induced effects by glycine and transport inhibitors. Biol. Psychiat. 45:1999;668-679.
24. Jones S.R., Joseph J.D., Barak L.S., Caron M.G., Wightman R.M. Dopamine neuronal transport kinetics and effects of amphetamine. J. Neurochem. 73:1999;2406-2414.
25. Konradi C., Cole R.L., Heckers S., Hyman S.E. Amphetamine regulates gene expression in rat striatum via transcription factor CREB. J. Neurosci. 14:1994;5623-5634.
26. Lillrank S.M., O'Conor W.T., Saransaari P., Ungerstedt U. In vivo effects of local and systemic phencyclidine on the extracellular levels of catecholamines and transmitter amino acids in the dorsolateral striatum of anaesthetized rats. Acta Physiol. Scand. 150:1994;109-115.
27. Liu J., Nickolenko J., Sharp F.R. Morphine induces c-fos and JunB in striatum and nucleus accumbens via D1 and N-metil-D-aspartate receptors. Proc. Natl. Acad. Sci. U.S.A. 91:1994;8537-8541.
28. Mathe J.M., Nomikos G.G., Blakeman K.H., Svensson T.H. Differential actions of dizocilpine (MK-801) on the mezolimbic and mezocortical dopamine systems: role of neuronal activity. NeuroPharmacology. 38:1999;121-128.
29. Morgan J.I., Curran T. Stimulus-transcription coupling in the nervous system: involvment of the inducible proto-oncogenes fos and jun. Annu. Rev. Neurosci. 14:1991;421-451.
30. Nakki R., Sharp F.R., Sagar S.M., Honkaniemi J. Effects of phencyclidine on immediate early gene expression in the brain. J. Neurosci. Res. 45:1996;13-27.
31. Nestler E.J., Kelz M.B., Chen J. ΔDFosB: a molecular mediator of long-term neural and behavioral plasticity. Brain Res. 835:1999;10-17.
32. Nissen L.J., Gelly J.C., Hipskind R.A. Induction-independent recruitment of CREB binding protein to the c-fos serum response element throught interactions between the bromo domain and Elk-1. J. Biol. Chem. 276:2000;5213-5221.
33. Olney J.W., Farber N.B. Glutamate receptor dysfunction and schizophrenia. Arch. Gen. Psychiat. 52:1995;998-1007.
34. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J. Psychiat. Res. 33:1999;523-533.
35. Platenik J., Kuramoto N., Yoneda Y. Molecular mechanisms associated with long-term consolidation of the NMDA signals. Life Sci. 67:2000;335-364.
36. Ramirez S., Ali S.A.S., Robin P., Trouche D., Harel-Bellan A. The CREB-binding protein (CBP) cooperates with the serum response factor for transactivation of the c-fos serum response element. J. Biol. Chem. 272:1997;31016-31021.
37. Rivera V.M., Sheng M., Greenberg M.E. The inner core of the serum response element mediates both the rapid induction and subsequent repression of c-fos transcription following serum stimulation. Genes Dev. 4:1990;255-268.
38. Ryan W.A., Franza B.R., Gilman M.Z. Two distinct cellular phosphoproteins bind to the c-fos serum response element. EMBO J. 8:1989;1785-1792.
39. Sassone-Corsi P., Sisson J.C., Verma I.M. Transcriptional autoregulation of the proto-oncogene c-fos. Nature. 334:1998;314-319.
40. Sgambato V., Vanhoutte P., Pages C., Rogard M., Hipskind R., Besson M.J., Caboche J. In vivo expression and regulation of Elk-1, a target of the extracellular-regulated kinase signaling pathway, in the adult rat brain. J. Neurosci. 18:1997;214-226.
41. Sharp J.W. Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression. Brain Res. 758:1997;51-58.
42. Sheng M., McFadden G., Greenberg M. Membrane depolarization and calcium induce c-fos transcription via phosphorylation of transcription factor CREB. Neuron. 4:1990;571-582.
43. r 32 kDa)/protein phosphatase-1 pathway regulates dephosporylation of the NMDA receptor. J. Neurosci. 18(24):1998;10297-10303.
44. Steinpreis R.E. The behavioral and neurochemical effect of phencyclidine in humans and animals: some implications for modeling psychosis. Behav. Brain Res. 74:1995;45-55.
45. Steinpreis R.E., Salamone J.D. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Brain Res. 612:1992;263-270.
46. Tanaka K., Nogawa S., Nagata E., Suzuki S., Dembo T., Kosakai A., Fukuuch Y. Temporal profile of CREB phosphorylation after focal ischemia in rat brain. NeuroReport. 10:1999;2245-2250.
47. Treisman R. Identification of a protein-binding site that mediates transcriptional response of the c-fos gene to serum factors. Cell. 46:1986;567-574.
48. Vanhoute P., Bernier V., Guibert B., Pages C., Besson M.J., Hipskind R.A., Caboche J. Glutamate induces phosphorylation of Elk-1 and CREB, along with c-fos activation, via an extracellular signal-regulated kinase-dependent pathway in brain slices. Mol. Cell. Biol. 19:1999;136-146.
49. Vukosavic S., Ruzdijic S., Veskov R., Rakic L.J., Kanazir S. Differential effects of amphetamine and phencyclidine on the expression of growth-associated protein GAP-43. Neurosci. Res. 40:2001;133-140.
50. Wang Y., Prywe R. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene. 19:2000;1379-1385.
51. Wheaton K., Atadja P., Riabowol K. Regulation of transcription factor activity during cellular aging. Biochem. Cell. Biol. 74:1996;523-534.